GlassScriptPhysician profile
Derek A Pawich
NPI 1184076069
$6,484.78
in general payments reported to CMS, 2019-2025
26 companies · $1,524 in 2025
The $1,524 reported for 2025 was more than what 78% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,580 · 2020: $279 · 2021: $1,329 · 2022: $568 · 2023: $456 · 2024: $749 · 2025: $1,524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,416 · Long Term Medical Supply Or Device Loan: $314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,415.76 |
| Long Term Medical Supply Or Device Loan | $313.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Southern Edge Orthopaedics, INC. | $1,409.00 | 2019 | |
| Arthrex, INC. | $1,200.00 | 2021 | |
| Treace Medical Concepts, INC. | $663.66 | 2022-2025 | |
| Acera Surgical, INC. | $513.68 | 2022-2025 | Restrata Wound Matrix |
| Integra Lifesciences Corporation | $491.23 | 2019-2025 | Integra, Acell, Integra Dermal Regeneration Template |
| Organogenesis INC. | $411.25 | 2023-2025 | Apligraf, Affinity, Puraply Wound Matrix |
| Paratek Pharmaceuticals, INC. | $260.36 | 2022-2025 | Nuzyra |
| Shockwave Medical, INC | $164.49 | 2025 | |
| Abbott Laboratories | $148.97 | 2023-2025 | Freestyle Libre 3, Proclaim |
| Novo Nordisk INC | $145.86 | 2023-2025 | Wegovy |
| Crossroads Extremity Systems, LLC | $145.81 | 2020 | |
| Djo, LLC | $133.25 | 2019-2025 | Cmf |
| Penumbra, INC. | $116.05 | 2025 | Penumbra System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $114.03 | 2024 | Jardiance |
| Orthofix Medical, INC. | $109.00 | 2020-2025 | Spinal-Stim, Physio-Stim, Spinal-Stim |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $97.32 | 2020 | |
| Stimwave Technologies Incorporated | $95.31 | 2021 | |
| Medtronic, INC. | $76.16 | 2023-2024 | Intellis Adaptivestim |
| Smith+Nephew, INC. | $65.19 | 2022-2023 | Collagenase Santyl, Regranex |
| Dexcom, INC. | $24.05 | 2024 | Dexcom G6 Transmitter |
| Tactile Systems Technology INC | $19.58 | 2023 | Flexitouch Plus, Entre Plus |
| Aroa Biosurgery Incorporated | $19.34 | 2019 | |
| Lilly USA, LLC | $16.71 | 2025 | Mounjaro, Zepbound |
| Biotissue Holdings INC. | $16.35 | 2023 | |
| Merck Sharp & Dohme LLC | $15.03 | 2019 | |
| Urgo Medical North America, LLC | $13.10 | 2024 | Urgoclean Ag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Pawich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.